Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen for prevention of post-ERCP pancreatitis
RBR-6zkm5kPhase 4Completed
- Sponsor
- Julio Carlos Pereira Lima
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ketoprofen in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) and acute pancreatitis (AP) (2 arms), sponsored by Julio Carlos Pereira Lima. Started Mar 2014; status: completed.
02
Drugs
ketoprofen
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)acute pancreatitis (AP)
Beyond the preview
Go deeper on RBR-6zkm5k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6zkm5k.